Zobrazeno 1 - 10 of 631 pro vyhledávání: '"Hubler R"'
1
Akademický článek
Estimating the burden of vaccine preventable lower respiratory tract disease in primary care, UK: protocol for a prospective surveillance study (AvonCAP GP2).
Autor: Duncan P; Centre for Academic Primary Care, University of Bristol, Bristol, United Kingdom polly.duncan@bristol.ac.uk.; Bristol Vaccine Centre, Schools of Population Health Science and of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Mears R; Centre for Academic Primary Care, University of Bristol, Bristol, United Kingdom.; Bristol Vaccine Centre, Schools of Population Health Science and of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Begier E; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, United States., Halvaei SR; Bristol Vaccine Centre, Schools of Population Health Science and of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Southern J; Evidence Generation, Pfizer Inc, Collegeville, United States., Porter SB; Bristol Vaccine Centre, Schools of Population Health Science and of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Hubler R; Evidence Generation, Pfizer Inc, Collegeville, United States., Oben G; Bristol Vaccine Centre, Schools of Population Health Science and of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Qian G; Bristol Vaccine Centre, Schools of Population Health Science and of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Lahuerta M; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, United States., Davis T; Centre for Academic Primary Care, University of Bristol, Bristol, United Kingdom., Campling J; Vaccines Medical Affairs, Pfizer Ltd, Tadworth, United Kingdom., Christensen H; Bristol Vaccine Centre, Schools of Population Health Science and of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Oliver J; Bristol Vaccine Centre, Schools of Population Health Science and of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Morales-Aza B; Bristol Vaccine Centre, Schools of Population Health Science and of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Pan K; EvGen Statistics, Pfizer Research and Development, Pfizer Inc, Collegeville, United States., Gray S; Evidence Generation, Pfizer Inc, Collegeville, United States., Hyams C; Bristol Vaccine Centre, Schools of Population Health Science and of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Danon L; School of Engineering Mathematics and Technology, University of Bristol, Bristol, United Kingdom., Gessner BD; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, United States.; West of England NIHR Clinical Research Network, Bristol, United Kingdom., Finn A; Bristol Vaccine Centre, Schools of Population Health Science and of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Hay AD; Centre for Academic Primary Care, University of Bristol, Bristol, United Kingdom.
Publikováno v: BJGP open [BJGP Open] 2024 Oct 02. Date of Electronic Publication: 2024 Oct 02.
Zobrazit plný text záznamu
3
Akademický článek
Adverse effects of sterilization processes on the fundamental topographic properties of modified dental implant surfaces.
Autor: Kunrath MF; Department of Biomaterials, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, P.O. Box 412, SE 405 30, Göteborg, Sweden. marcel.kunrath@biomaterials.gu.se.; School of Health and Life Sciences, Post-Graduate Program in Dentistry, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil. marcel.kunrath@biomaterials.gu.se.; School of Technology, Post-Graduate Program in Materials Technology and Engineering, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil. marcel.kunrath@biomaterials.gu.se., Hubler R; School of Technology, Post-Graduate Program in Materials Technology and Engineering, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Dahlin C; Department of Biomaterials, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, P.O. Box 412, SE 405 30, Göteborg, Sweden.
Publikováno v: Journal of materials science. Materials in medicine [J Mater Sci Mater Med] 2024 Jul 29; Vol. 35 (1), pp. 44. Date of Electronic Publication: 2024 Jul 29.
Zobrazit plný text záznamu
4
Akademický článek
Relative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United States.
Autor: Anderson EJ; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States.; Pfizer, Inc. Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, PA, United States., Tippett A; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Begier E; Pfizer, Inc. Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, PA, United States., Gibson T; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Ess G; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Patel V; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Taylor M; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Reese O; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Salazar L; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Jadhao S; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Sun HY; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Hsiao HM; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Gupta S; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Li W; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Stephens K; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Keane A; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Ciric C; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Hellmeister K; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States., Cheng A; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States., Al-Husein Z; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States., Bristow L; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States., Hubler R; Pfizer, Inc. Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, PA, United States., Liu Q; Pfizer, Inc. Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, PA, United States., Gessner BD; Pfizer, Inc. Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, PA, United States., Jodar L; Pfizer, Inc. Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, PA, United States., Swerdlow D; Pfizer, Inc. Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, PA, United States., Kalina W; Pfizer, Inc. Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, PA, United States., Uppal S; Pfizer, Inc. Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, PA, United States., Kamidani S; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Rouphael N; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States., Anderson LJ; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States., Rostad CA; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States.
Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Jul 12. Date of Electronic Publication: 2024 Jul 12.
Zobrazit plný text záznamu
5
Akademický článek
Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case-Control Study.
Autor: Keane A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA., Tippett A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA., Taylor EG; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA., Reese O; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA., Salazar L; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA., De Castro K; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA., Choi C; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA., Ciric C; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA., Taylor M; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA., Mitchell A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA., Gibson T; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA., Puzniak L; Pfizer, Inc., New York, NY 10017, USA., Hubler R; Pfizer, Inc., New York, NY 10017, USA., Valluri SR; Pfizer, Inc., New York, NY 10017, USA., Wiemken TL; Pfizer, Inc., New York, NY 10017, USA., Lopman BA; Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA., Kamidani S; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA 30322, USA., Anderson LJ; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA 30322, USA., McLaughlin JM; Pfizer, Inc., New York, NY 10017, USA., Rostad CA; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA 30322, USA., Anderson EJ; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA 30322, USA.; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
Publikováno v: Vaccines [Vaccines (Basel)] 2024 Jun 13; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 13.
Zobrazit plný text záznamu
6
Akademický článek
Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older Adults.
Autor: Tippett A; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Ess G; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Hussaini L; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Reese O; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Salazar L; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Kelly M; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Taylor M; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Ciric C; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Keane A; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Cheng A; Department of Medicine, Hope Clinic, Emory University School of Medicine, Atlanta, Georgia, USA., Gibson T; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Li W; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Hsiao HM; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Bristow L; Department of Medicine, Hope Clinic, Emory University School of Medicine, Atlanta, Georgia, USA., Hellmeister K; Department of Medicine, Hope Clinic, Emory University School of Medicine, Atlanta, Georgia, USA., Al-Husein Z; Department of Medicine, Hope Clinic, Emory University School of Medicine, Atlanta, Georgia, USA., Hubler R; Pfizer, Inc,New York, New York, USA., Begier E; Pfizer, Inc,New York, New York, USA., Liu Q; Pfizer, Inc,New York, New York, USA., Gessner B; Pfizer, Inc,New York, New York, USA., Swerdlow DL; Pfizer, Inc,New York, New York, USA., Kamidani S; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Kao C; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Yildirim I; Department of Pediatrics (Infectious Diseases), Yale-New Haven Hospital, New Haven, Connecticut, USA.; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.; Yale School of Public Health, Yale Institute for Global Health, New Haven, Connecticut, USA.; Center for Infection and Immunity, Yale School of Medicine, New Haven, Connecticut, USA., Rouphael N; Department of Medicine, Hope Clinic, Emory University School of Medicine, Atlanta, Georgia, USA., Rostad CA; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Anderson EJ; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Medicine, Hope Clinic, Emory University School of Medicine, Atlanta, Georgia, USA.
Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Apr 10; Vol. 78 (4), pp. 1065-1072.
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Nano-scaled surfaces and sustainable-antibiotic-release from polymeric coating for application on intra-osseous implants and trans-mucosal abutments.
Autor: Kunrath MF; Department of Biomaterials, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, P.O. Box 412, SE 405 30 Göteborg, Sweden; School of Health and Life Sciences, Post-Graduate Program in Dentistry, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil; Toxicology and Pharmacology Research Center (INTOX),School of Health and Life Sciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil; School of Technology, Post-Graduate Program in Materials Technology and Engineering, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil. Electronic address: marcel.kunrath@biomaterials.gu.se., Rubensam G; Toxicology and Pharmacology Research Center (INTOX),School of Health and Life Sciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Rodrigues FVF; Brain Institute of Rio Grande do Sul (InsCer), Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Marinowic DR; Brain Institute of Rio Grande do Sul (InsCer), Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Sesterheim P; Experimental Cardiology Center, Institute of Cardiology of Rio Grande do Sul, Porto Alegre, RS, Brazil., de Oliveira SD; School of Health and Life Sciences, Post-Graduate Program in Dentistry, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Teixeira ER; School of Health and Life Sciences, Post-Graduate Program in Dentistry, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Hubler R; School of Technology, Post-Graduate Program in Materials Technology and Engineering, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
Publikováno v: Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2023 Aug; Vol. 228, pp. 113417. Date of Electronic Publication: 2023 Jun 19.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje